在急性护理入院期间为老年人取消处方:一个范围审查协议
Erika Sprake1, Janice Kung2, Michelle Graham3
1Division of Geriatric Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada.
JBI evidence synthesis
|July 15, 2024
概括
本范围审查考察了急性护理中老年人 (60岁以上) 的抑郁症,探索当前的做法,可行性,挑战和结果. 它强调需要在医院环境中进行更多的研究,以管理多药制药的风险.
科学领域:
- 老年医学 老年医学
- 药理学 药理学是指药理学的学科.
- 医疗保健服务研究 医疗服务研究
背景情况:
- 多药在老年人中很常见,增加了患者的风险.
- 大多数描述抑郁症的研究都集中在门诊机构.
- 急症护理提供了一个独特的环境,用于处方抑郁症干预.
研究的目的:
- 在急性护理环境中对60岁及以上成年人抑郁症的现有知识进行映射.
- 识别抑郁症描述活动,可行性,挑战和结果.
- 了解目前在医院环境中进行抑郁症研究的现状.
主要方法:
- 以JBI方法论为指导的范围审查.
- 在多个数据库 (MEDLINE,Scopus,Web of Science,CINAHL,Embase,Cochrane) 中进行全面搜索.
- 包括定性,定量,混合方法研究,指导方针和意见文件;排除系统性/范围审查.
主要成果:
- 该综述综合了当前关于急性护理中老年人抑郁症的知识.
- 识别了所进行的描述活动及其可行性.
- 文件与住院患者和出院患者相关的挑战和结果.
结论:
- 在老年人急性护理中处方是新兴的研究领域,具有重大影响.
- 需要进一步的研究,以优化医院环境中的抑郁症策略.
- 综合证据支持开发有针对性的干预措施,以改善老年住院患者的药物管理.
相关概念视频
Antidepressant Drugs: Overview
430
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
430
Drug Dosage Regimen: Overview
3.5K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.5K
Drug Therapy
41
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
41
Psychosis: Goals of Pharmacotherapy
119
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
119
Factors Affecting Drug Response: Overview
2.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
CNS Depressants: Barbiturates and Benzodiazepines
243
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
243


